Results 1 to 10 of about 192,841 (253)

Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion. [PDF]

Int Ophthalmol, 2023
Gildea D, Tang B, Baily C, Ryan A.
europepmc   +1 more source

Long-term disease control with anti-VEGF treat-and-extend treatment in macular edema due to retinal vein occlusion. [PDF]

BMC Ophthalmol
Fischer S, Hoffmann L, Hatz K.
europepmc   +1 more source

Multimodal imaging biomarkers associated with recurrence of diabetic macular edema during aflibercept treat-and-extend therapy. [PDF]

Sci Rep
Kim K, Lee J, Choi J, Yu SY.
europepmc   +1 more source

Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel. [PDF]

Eye (Lond)
Gale R, Awad MH, Bailey C, Cackett P, Chhabra R, Downey L, Ghanchi F, Kotagiri A, Narendran N, Pearce I, Peto T, Sivaprasad S, Younis S, Napier J, Gilbert R, Ismat S.   +15 more
europepmc   +1 more source

Clinical outcome using a modified treat-and-extend protocol for neovascular age-related macular degeneration. [PDF]

BMJ Open Ophthalmol, 2022
Vofo BN, Cnaany Y, Chowers I.
europepmc   +1 more source

Efficacy of a Modified Treat-and-Extend Aflibercept Regimen for Macular Oedema in Eyes with Central Retinal Vein Occlusion: 2-Year Prospective Study. [PDF]

J Clin Med, 2023
Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Kawashima H, Yanagi Y.   +6 more
europepmc   +1 more source

Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis. [PDF]

Eye (Lond), 2023
Nichani PAH, Popovic MM, Dhoot AS, Pathak A, Muni RH, Kertes PJ.   +5 more
europepmc   +1 more source

Management and safety of same day bilateral intravitreal anti-VEGF injections in a treat-and-extend regimen. [PDF]

BMC Ophthalmol
Plasencia C, Eschle J, Hatz K.
europepmc   +1 more source

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing. [PDF]

J Clin Med
Wu KY, Qian SY, Camiré A, Kim DT, Giunta M.   +4 more
europepmc   +1 more source

The need for a pragmatic, individualized treat-and-extend (T&E) treatment paradigm for centre-involving diabetic macular oedema. [PDF]

Eye (Lond), 2023
Chaudhary V, Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group.   +1 more
europepmc   +1 more source